Emerald Health Therapeutics Inc. (EHT) (TSXV:EMH) (OCTQX:EMHTF) today announced that its wholly owned subsidiary, Emerald Health Botanicals Inc., has completed a purchase of dried cannabis from Supreme Pharmaceuticals Inc.’s (TSXV:FIRE) subsidiary, 7ACRES.
InMed Pharmaceuticals (CSE: IN, OTCQB: IMLFF) announced today that it has retained the consulting services of Ben Paterson, P.E., to assist in defining the pathway for the scale-up, purification, and manufacturing strategies for InMed’s cannabinoid biosynthesis program.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced that it has received total proceeds of nearly $11.9 million from the exercise of an aggregate of 19,185,965 warrants since the closing of its acquisition of ABcann Medicinals Inc. on April 28, 2017.
he Green Organic Dutchman Holdings Ltd. announces the syndicate for the offering of 4,242,500 Units of the Company at a price of C$1.65 per Unit for aggregate gross proceeds of C$7,000,125.
ABcann Global receives $11.9 Million from the exercise of outstanding warrants.
StockHouse did an in-depth look at InMed Pharmaceuticals (CSE: IN, OTCQB: IMLFF) about their model, technology and the "Big Picture"
ABcann Global receives $11.9 Million from the exercise of outstanding warrants.
The Seed Investor sits down with ABcann CEO Aaron Keay to discuss ABcann and what it takes to be the strongest grower in the Marijuana sector.
Ken Clement said in an update published on the ABcann website. “Providing a high quality, standardized pesticide-free product to our patients remains our number one priority as we initiate our largest expansion plans to date.”
InMed Pharmaceuticals (CSE: IN OTCBB: IMLFF) is picking up steam, with another recent article in MMJReporter.com
Canopy Growth Corporation (TSX: WEED) and the Province of New Brunswick today announced a significant milestone in the history of Canadian cannabis, entering into an agreement to guarantee a reliable and high-quality supply of cannabis products into New Brunswick's retail stores.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has revolutionized oral CBD intake, having engineered the product to enhance absorption through the intestinal tract without active compounds being destroyed by stomach acid or broken down by the liver, and this revolutionary product also masks the unpleasant flavor of cannabis compounds.
Cronos Group expects to issue up to 4,444,444 common shares at $2.25
Canopy Growth Corporation (TSX:WEED) has completed an agreement with Cannabis Care Canada Inc. to sell its wholly-owned subsidiary Mettrum (Bennett North) Ltd. , which is licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations to produce and sell dried cannabis and cannabis oil.
Eaze, the leading cannabis technology company, announced today an additional $27 million in Series B financing, led by Bailey Capital with participation from DCM Ventures, Kaya Ventures and FJ Labs.
